Clinical complications in outpatient myelodysplastic syndromes

Abstract

The outcome of myelodysplastic syndromes (MDS) depends on both progression to acute leukemia and complications development. During a 18-months observation period, non-toxic complications emerging in 48 outpatient MDS, of which 15 (31%) on active treatment and 33 (69%) receiving supportive measures alone, were recorded and analyzed. Out of 48 patients (median age of 72 years), 34 (71%) experienced complications; a total number of 92 events were recorded; most frequently observed events were infectious (38 events). Complications are a frequent issue in MDS; preventive measures should be increased and directed toward the most frequently observed complications.

Keywords

• Ambulatory Care
• Adverse Effects
• Complications
• Infection
• Myelodysplastic Syndromes
• Quality of Life